• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型脂肪酸酰胺水解酶抑制剂氚标记的PF-622的制备

Preparation of tritium-labeled PF-622, a novel fatty acid amide hydrolase inhibitor.

作者信息

Zhang Yinsheng

机构信息

Chemical R&D, Pfizer Inc, Groton, CT, USA.

出版信息

J Labelled Comp Radiopharm. 2017 Nov;60(13):608-615. doi: 10.1002/jlcr.3559. Epub 2017 Sep 21.

DOI:10.1002/jlcr.3559
PMID:28869999
Abstract

To make a detailed characterization of the mechanism of inhibition and selectivity of a novel fatty acid amide hydrolase inhibitor PF-622, 3 tritium isotopomers were prepared. [ H]PF-622a labeled at the piperazine ring B and [ H]PF-622b labeled at both the ring B and phenyl ring A were synthesized via catalytic H(hydrogen)-T(tritium) exchange, utilizing 1 equiv and excess of Crabtree's catalyst, respectively. The preparation of [ H]PF-622c labeled only at the phenyl ring A was achieved via tritiodebromination of the bromide precursor, using Pd(PPh ) as a catalyst. The observations from these tritiation reactions might open a new perspective in the labeling for the targets having a similar moiety.

摘要

为了详细表征新型脂肪酸酰胺水解酶抑制剂PF-622的抑制机制和选择性,制备了3种氚同位素异构体。通过催化氢(H)-氚(T)交换分别使用1当量和过量的克拉布特里催化剂合成了在哌嗪环B上标记的[³H]PF-622a和在环B和苯环A上均标记的[³H]PF-622b。仅在苯环A上标记的[³H]PF-622c是通过使用Pd(PPh₃)₄作为催化剂对溴化物前体进行氚代脱溴反应制备的。这些氚化反应的观察结果可能为具有相似部分的靶标的标记开辟新的视角。

相似文献

1
Preparation of tritium-labeled PF-622, a novel fatty acid amide hydrolase inhibitor.新型脂肪酸酰胺水解酶抑制剂氚标记的PF-622的制备
J Labelled Comp Radiopharm. 2017 Nov;60(13):608-615. doi: 10.1002/jlcr.3559. Epub 2017 Sep 21.
2
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.具有显著选择性的新型脂肪酸酰胺水解酶抑制剂的作用机制类别
Biochemistry. 2007 Nov 13;46(45):13019-30. doi: 10.1021/bi701378g. Epub 2007 Oct 19.
3
The synthesis of one H-2 labeled and two H-3 labeled leukotriene C4 synthase inhibitors.一种 H-2 标记和两种 H-3 标记白三烯 C4 合酶抑制剂的合成。
J Labelled Comp Radiopharm. 2020 Aug;63(10):434-441. doi: 10.1002/jlcr.3862. Epub 2020 Jul 7.
4
Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).哌嗪和哌啶甲酰胺及氨基甲酸酯类作为脂肪酸酰胺水解酶(FAAH)和单酰甘油脂肪酶(MAGL)的抑制剂。
Bioorg Med Chem. 2014 Dec 1;22(23):6694-6705. doi: 10.1016/j.bmc.2014.09.012. Epub 2014 Sep 16.
5
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.从生物活性分子中挖掘脂肪酸酰胺水解酶(FAAH)抑制剂:苯丁锡和安比西林被鉴定为 FAAH 抑制剂。
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6793-6. doi: 10.1016/j.bmcl.2009.09.086. Epub 2009 Sep 30.
6
Carbon-13 and carbon-14 labeled dabigatran etexilate and tritium labeled dabigatran.
J Labelled Comp Radiopharm. 2016 Dec;59(14):648-656. doi: 10.1002/jlcr.3402. Epub 2016 May 5.
7
Synthesis of ximelagatran, melagatran, hydroxymelagatran, and ethylmelagatran in H-3 labeled form.以H-3标记形式合成希美加群、美拉加群、羟基美拉加群和乙基美拉加群。
J Labelled Comp Radiopharm. 2013 May 30;56(6):334-7. doi: 10.1002/jlcr.3028. Epub 2013 Feb 16.
8
Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).脂肪酸酰胺水解酶(FAAH)的苯并噻吩哌嗪和哌啶脲抑制剂。
Bioorg Med Chem Lett. 2009 May 15;19(10):2865-9. doi: 10.1016/j.bmcl.2009.03.080. Epub 2009 Mar 24.
9
Synthesis and characterization of tritium labeled N-((R)-1-((S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl)-3-methyl-1-oxobutan-2-yl)-3-sulfamoylbenzamide.
J Labelled Comp Radiopharm. 2015 Aug;58(10):414-8. doi: 10.1002/jlcr.3320. Epub 2015 Jul 31.
10
Evaluation of the efficiency of Pd/H2 -catalyzed benzylic H/D exchange of dehydroabietinal with D(2) O and synthesis of a tritium-labeled analogue.钯/氢气催化脱氢枞醛与重水进行苄基氢/氘交换的效率评估及一种氚标记类似物的合成
J Labelled Comp Radiopharm. 2014 Jan;57(1):53-6. doi: 10.1002/jlcr.3117. Epub 2013 Sep 23.